Aeglea BioTherapeutics

FF Pharmaceuticals

This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.

Caldera Therapeutics

This clinical-stage biotechnology company develops bispecific antibodies to treat patients with inflammatory bowel disease and other immune-mediated conditions.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.

Timberlyne

This biopharmaceutical company develops monoclonal antibody therapies for patients with autoimmune disorders and cancers.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

AgomAb Therapeutics

This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.